Association between nonalcoholic fatty liver disease and colorectal adenoma: A systematic review and meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 1, 2015, Pages 322-333

  Ding, Wenjin ^a   Fan, Jiangao ^a   Qin, Jianjun ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Colorectal adenoma; Meta analysis; Nonalcoholic fatty liver disease; Risk factors

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGE; ARTICLE; BODY MASS; COLORECTAL ADENOMA; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; GENDER; HUMAN; HYPERGLYCEMIA; HYPERTENSION; META ANALYSIS; NONALCOHOLIC FATTY LIVER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR VOLUME; WAIST CIRCUMFERENCE;

EID: 84923205820     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Chalasani N, Younossi Z, Lavine JE, Dieh AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ; American Association for the Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Association. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-609.
2. Pan JJ, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol 2014; 6: 274-283.
3. Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 2009; 9: 299-314.
4. Hui E, Xu A, Bo Yang H, Lam KS. Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines. J Diabetes Investig 2013; 4: 413-425.
5. Ryoo JH, Suh YJ, Shin HC, Cho YK, Choi JM, Park SK. Clinical association between non-alcoholic fatty Liver disease and the development of hypertension. J Gastroenterol Hepatol 2014; [Epub ahead of print].
6. Kargulewicz A, Stankowiak-Kulpa H, Grzy-misławski M. Dietary recommendations for patients with nonalcoholic fatty liver disease. Prz Gastroenterol 2014; 9: 18-23.
7. Sawbridge D, Probert C. Population-based screening in colorectal cancer - current practice and future developments: faecal biomarkers review. J Gastrointestin Liver Dis 2014; 23: 195-202.
8. Huang KW, Leu HB, Wang YJ, Luo JC, Lin HC, Lee FY, Chan WL, Lin JK, Chang FY. Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy. Colorectal Dis 2013; 15: 830-835.
9. Hwang ST, Cho YK, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Won KH, Jin W. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol 2010; 25: 562-567.
10. Touzin NT, Bush KN, Williams CD, Harrsion SA. Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease. Therap Adv Gastroenterol 2011; 4: 169-176.
11. Kang HW, Kim D, Kim HJ, Kim CH, Kim YS, Park MJ, Kim JS, Cho SH, Sung MW, Jung HC, Lee HS, Song IS. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study. Am J Gastroenterol 2010; 105: 178-187.
12. Kim KS, Moon HJ, Choi CH, Baek EK, Lee SY, Cha BK, Lee HW, Kim HJ, Do JH, Chang SK. The Frequency and Risk Factors of Colorectal Adenoma in Health-Check-up Subjects in South Korea: Relationship to Abdominal Obesity and Age. Gut Liver 2010; 4: 36-42.
13. Lin XF, Shi KQ, You J, Liu WY, Luo YW, Wu FL, Chen YP, Wong DK, Yuen MF, Zheng MH. Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study. Mol Biol Rep 2014; 41: 2989-2997.
14. Stadlmayr A, Aigner E, Steger B, Scharinger L, Lederer D, Mayr A, Strasser M, Brunner E, Heuberger A, Hohla F, Steinwendner J, Patsch W, Datz C. Nonalcoholic fatty liver disease: an indepent risk factor for colorectal neoplasia. J Intern Med 2011; 270: 41-49.
15. Wong VW, Wong GL, Tsang SW, Fan T, Chu WC, Woo J, Chan AW, Choi PC, Chim AM, Lau JY, Chan FK, Sung JJ, Chan HL. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011; 60: 829-836.
16. Miele L, Marrone G, Lauritano C, Cefalo C, Gasbarrini A, Day C, Grieco A. Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. Curr Pharm Des 2013; 19: 5314-5324.
17. Muhidin SO, MAgan AA, Osman KA, Syed S, Ahmed MH. The relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome. J Obes 2012; 2012: 637538.
18. Min YW, Yun HS, Chang WI, Kim JY, Kim YH, Son HJ, Kim JJ, Rhee JC, Chang DK. Influence of non-alcoholic fatty liver disease on the prognosis in patients with colorectal cancer. Clin Res Hepatol Gastroenterol 2012; 36: 78-83.
19. Eslamparast T, Eghtesad S, Hekmatdoost A, Poustchi H. Probiotics and Nonalcoholic Fatty liver Disease. Middle East J Dig Dis 2013; 5: 129-136.
20. Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, McGilvray ID, Allard JP. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 2013; 58: 120-127.
21. Zhu JZ, Wang YM, Zhou QY, Zhu KF, Yu CH, Li YM. Systematic review with meta-analysis: alcohol consumption and the risk of colorectal adenoma. Aliment Pharmacol Ther 2014; [Epub ahead of print].
22. Yamada A, Minamiguchi S, Sakai Y, Horimatsu T, Muto M, Chiba T, Boland CR, Goel A. Colorectal Advanced Neoplasms Occur through Dual Carcinogenesis Pathways in Individuals with Coexisting Serrated Polyps. PLoS One 2014; 9: e98059.
23. Alecu M, Simion L, Straja N, Brătucu E. Multiple Polyps and Colorectal Cancer. Chirurgia (Bucur) 2014; 109: 342-346.
24. Kim EH, Kim HK, Bae SJ, Chang HS, Park HW, Do MY, Kim KJ, Jung CH, Lee WJ, Park JY, Choe J. Fasting serum insulin levels and insulin resistance are associated with colorectal adenoma in Koreans. J Diabetes Investig 2014; 5: 297-304.
25. Vu HT, Ufere N, Yan Y, Wang JS, Early DS, Elwing JE. Diabetes mellitus increases risk for colorectal adenomas in younger patients. World J Gastroenterol 2014; 20: 6946-6952.
26. Riondino S, Roselli M, Palmirotta R, Della-Morte D, Ferroni P, Guadagni F. Obesity and colorectal cancer: role of adipokines in tumor initiation and progression. World J Gastroenterol 2014; 20: 5177-5190.
27. Oh JS, Kim HH, Hwang HS, Yun DY, Kim BS, Lee CH, Han J, Kim HG, Jung JT, Kwon JG, Kim EY. Comparison of blood leptin concentration and colonic mucosa leptin expression in colon adenoma patients and healthy control. Korean J Gastroenterol 2014; 63: 354-360.
28. Ding WJ, Wang Y, Fan JG. Regulation of adipokines by polyunsaturated fatty acids in a rat model of non-alcoholic steatohepatitis. Arch Iran Med 2014; 17: 563-567.
29. Bora A, Alptekin C, Yavuz A, Batur A, Akdemir Z, Berköz M. Assessment of liver volume with computed tomography and comparison of findings with ultrasonography. Abdom Imaging 2014; [Epub ahead of print].
30. Khov N, Sharma A, Riley TR. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20: 6821-6825.
31. Amarapurkar DN, Dharod M, Gautam S, Patel N. Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis. Trop Gastroenterol 2013; 34: 159-63.
32. Shibahara J, Ando S, Sakamoto Y, Kokudo N, Fukayama M. Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients. Histopathology 2014; 64: 951-962.